表紙
市場調查報告書
商品編碼
925593

Medsuite:澳洲的整形外科生醫材料市場 (2020-2026年)

Orthopedic Biomaterials Market Report Suite - Australia - 2020-2026 - Medsuite

出版日期: | 出版商: iData Research Inc. | 英文 285 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供澳洲的整形外科生醫材料的市場調查,市場背景,產品系列,骨移植片,去礦物質骨基質(DBM)移植片,合成骨等骨移植片替代品,整形外科用生長因子,玻尿酸粘性劑的市場規模的變化、預測,用了這些材料的整形外科治療數量,市場成長的各種影響因素分析,競爭環境,市場佔有率,主要企業簡介等資訊彙整。

產品的評估

  • 簡介
  • 產品系列
  • 法規上的課題、回收
  • 臨床試驗

澳洲的整形外科生醫材料市場:市場概要

  • 簡介
    • 移植骨替代物
    • 生長因子
    • 玻尿酸(HA)增稠劑
  • 匯率
  • 市場概要、趨勢分析
  • 成長推動因素、抑制因素
  • 企業佔有率分析
  • M&A
  • 企業簡介
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation
    • Zimmer Biomet
  • SWOT分析

手術數量

  • 簡介
  • 手術數量:各類型
    • 骨移植
    • 使用了生長因子的手術
    • 玻尿酸補充

整形外科用移植骨替代物市場

  • 簡介
  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 各材料
    • 各適應症
  • 成長推動因素、抑制因素
  • 企業佔有率分析

整形外科用生長因子市場

  • 簡介
    • BMP-2(Medtronic)
    • PDGF-BB(Wright Medical)
    • P-15合成小肽(Cerapedics)
    • P-15合成小肽(Biocomposites)
  • 成長推動因素、抑制因素
  • 企業佔有率分析

玻尿酸關節內補充市場

  • 簡介
  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 單回注射
    • 3次注射
  • 成長推動因素、抑制因素
  • 企業佔有率分析

簡稱

目錄
Product Code: iDATA_AUOB20_MS

Throughout this medical market research, iData Research analyzed 48 orthobiologics companies in Australia and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the Australian Orthopedic Biomaterials market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an orthobiologics procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered:

1. Procedure Volumes for the Australian Orthopedic Biomaterials Devices - MedPro

2. Orthopedic Bone Graft Substitute Market - MedCore

3. Orthopedic Growth Factor Market - MedCore

4. Hyaluronic Acid Viscosupplementation Market - MedCore

Australian Orthopedic Biomaterials Market Insights

With some exceptions, tissue supply for allografts and DBM allografts is constrained by the number of available donors. Furthermore, allografts are primarily sold by bone banks in Australia, which is attributed to a relatively high barrier to entry to the market for international companies.

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, over 15% of Australians were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

Overall, the Australia orthopedic biomaterials market was valued at $63.8 million in 2019. This is expected to increase over the forecast period at a CAGR of 4.9% to reach $89.4 million.

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, Australia, 2016 - 2026 2
  • Chart 1 2: Orthopedic Biomaterials Market Overview, Australia, 2019 & 2026 2
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, Australia, 2016 - 2026 71
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, Australia, 2019 72
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, Australia, 2026 73
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, Australia, 2016 - 2026 75
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, Australia, 2019 83
  • Chart 4 1: Orthopedic Biomaterials Market by Segment, Australia, 2016 - 2026 125
  • Chart 4 2: Orthopedic Bone Grafting Procedures by Material, Australia, 2016 - 2026 128
  • Chart 4 3: Autograft Procedures by Indication, Australia, 2016 - 2026 131
  • Chart 4 4: Allograft Procedures by Indication, Australia, 2016 - 2026 134
  • Chart 4 5: DBM Allograft Procedures by Indication, Australia, 2016 - 2026 137
  • Chart 4 6: Synthetic Procedures by Indication, Australia, 2016 - 2026 140
  • Chart 4 7: Orthopedic Bone Grafting Procedures by Indication, Australia, 2016 - 2026 143
  • Chart 4 8: Orthopedic Growth Factor Procedures, Australia, 2016 - 2026 145
  • Chart 4 9: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Australia, 2016 - 2026 147
  • Chart 5 1: Orthopedic Bone Graft Substitute Market by Material, Australia, 2016 - 2026 151
  • Chart 5 2: Orthopedic Bone Graft Substitute Market Breakdown by Material, Australia, 2019 152
  • Chart 5 3: Orthopedic Bone Graft Substitute Market Breakdown by Material, Australia, 2026 153
  • Chart 5 4: Orthopedic Bone Graft Substitute Market by Indication, Australia, 2016 - 2026 157
  • Chart 5 5: Orthopedic Bone Graft Substitute Market Breakdown by Indication, Australia, 2019 158
  • Chart 5 6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, Australia, 2026 159
  • Chart 5 7: Total Orthopedic Bone Graft Substitute Market, Australia, 2016 - 2026 161
  • Chart 5 8: Allograft Bone Graft Substitute Market, Australia, 2016 - 2026 163
  • Chart 5 9: Allograft Bone Graft Substitute Market by Indication, Australia, 2016 - 2026 165
  • Chart 5 10: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Australia, 2016 - 2026 179
  • Chart 5 11: Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication, Australia, 2016 - 2026 181
  • Chart 5 12: Synthetic Bone Graft Substitute Market, Australia, 2016 - 2026 195
  • Chart 5 13: Synthetic Bone Graft Substitute Market by Indication, Australia, 2016 - 2026 197
  • Chart 5 14: Spine Bone Graft Substitute Market, Australia, 2016 - 2026 211
  • Chart 5 15: Cervical Spine Bone Graft Substitute Market, Australia, 2016 - 2026 213
  • Chart 5 16: Thoracolumbar Spine Bone Graft Substitute Market, Australia, 2016 - 2026 215
  • Chart 5 17: Trauma Bone Graft Substitute Market, Australia, 2016 - 2026 217
  • Chart 5 18: Non-Union Trauma Bone Graft Substitute Market, Australia, 2016 - 2026 219
  • Chart 5 19: Fresh Fracture Trauma Bone Graft Substitute Market, Australia, 2016 - 2026 221
  • Chart 5 20: Large Joint Reconstruction Bone Graft Substitute Market, Australia, 2016 - 2026 223
  • Chart 5 21: Hip Reconstruction Bone Graft Substitute Market, Australia, 2016 - 2026 225
  • Chart 5 22: Knee Reconstruction Bone Graft Substitute Market, Australia, 2016 - 2026 227
  • Chart 5 23: Foot Reconstruction Bone Graft Substitute Market, Australia, 2016 - 2026 229
  • Chart 5 24: Craniomaxillofacial Bone Graft Substitute Market, Australia, 2016 - 2026 231
  • Chart 5 25: Oncology Bone Graft Substitute Market, Australia, 2016 - 2026 233
  • Chart 5 26: Leading Competitors, Orthopedic Bone Graft Substitute Market, Australia, 2019 239
  • Chart 6 1: Orthopedic Growth Factor Market, Australia, 2016 - 2026 243
  • Chart 6 2: Leading Competitors, Orthopedic Growth Factor Market, Australia, 2019 248
  • Chart 7 1: Hyaluronic Acid Viscosupplementation Market by Segment, Australia, 2016 - 2026 254
  • Chart 7 2: Hyaluronic Acid Viscosupplementation Market Breakdown, Australia, 2019 255
  • Chart 7 3: Hyaluronic Acid Viscosupplementation Market Breakdown, Australia, 2026 256
  • Chart 7 4: Total Hyaluronic Acid Viscosupplementation Market, Australia, 2016 - 2026 258
  • Chart 7 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, Australia, 2016 - 2026 260
  • Chart 7 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, Australia, 2016 - 2026 262
  • Chart 7 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2019 267